110 related articles for article (PubMed ID: 2573732)
21. Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolytic agent.
Patel JB; Malick JB
Eur J Pharmacol; 1982 Mar; 78(3):323-33. PubMed ID: 6121711
[TBL] [Abstract][Full Text] [Related]
22. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate.
Shimizu H; Hirose A; Tatsuno T; Nakamura M; Katsube J
Jpn J Pharmacol; 1987 Dec; 45(4):493-500. PubMed ID: 2895201
[TBL] [Abstract][Full Text] [Related]
24. Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies.
Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
J Med Chem; 1988 Jul; 31(7):1382-92. PubMed ID: 2898533
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships in thienodiazepine and benzodiazepine derivatives.
Chimirri A; Gitto R; Grasso S; Zappalà M; De Sarro A; Battista De Sarro G
Farmaco; 1994 Mar; 49(3):193-6. PubMed ID: 8043171
[TBL] [Abstract][Full Text] [Related]
26. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
[TBL] [Abstract][Full Text] [Related]
27. Preclinical studies with pyrazolopyridine non-benzodiazepine anxiolytics: ICI 190,622.
Patel JB; Meiners BA; Salama AI; Malick JB; U'Prichard DC; Giles RE; Goldberg ME; Bare TM
Pharmacol Biochem Behav; 1988 Apr; 29(4):775-9. PubMed ID: 2901116
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5-b][1,5]-, and pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity.
Chakrabarti JK; Hotten TM; Pullar IA; Steggles DJ
J Med Chem; 1989 Oct; 32(10):2375-81. PubMed ID: 2571731
[TBL] [Abstract][Full Text] [Related]
29. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
[TBL] [Abstract][Full Text] [Related]
30. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
Miklya I; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
[TBL] [Abstract][Full Text] [Related]
31. Benzodiazepine-induced hyperphagia in the nondeprived rat: comparisons with CL 218,872, zopiclone, tracazolate and phenobarbital.
Cooper SJ; Moores WR
Pharmacol Biochem Behav; 1985 Aug; 23(2):169-72. PubMed ID: 2865747
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVI. Derivatives of 1-acetoxy-7,7-dimethylbicyclo[2.2.2]octan-5-one-2,3-dicarboximide.
Kossakowski J; Hejchman E
Acta Pol Pharm; 2003; 60(1):61-6. PubMed ID: 12848369
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and structure-activity relationships of novel pyrazolo[5,1-b]thiazole derivatives as potent and orally active corticotropin-releasing factor 1 receptor antagonists.
Takahashi Y; Hashizume M; Shin K; Terauchi T; Takeda K; Hibi S; Murata-Tai K; Fujisawa M; Shikata K; Taguchi R; Ino M; Shibata H; Yonaga M
J Med Chem; 2012 Oct; 55(19):8450-63. PubMed ID: 22971011
[TBL] [Abstract][Full Text] [Related]
34. The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity.
New JS; Christopher WL; Yevich JP; Butler R; Schlemmer RF; VanderMaelen CP; Cipollina JA
J Med Chem; 1989 Jun; 32(6):1147-56. PubMed ID: 2542551
[TBL] [Abstract][Full Text] [Related]
35. Thiophene systems. 5. Thieno[3,4-b][1,5]benzoxazepines, thieno[3,4-b][1,5]benzothiazepines, and thieno[3,4-b][1,4]benzodiazepines as potential central nervous system agents.
Press JB; Hofmann CM; Eudy NH; Day IP; Greenblatt EN; Safir SR
J Med Chem; 1981 Feb; 24(2):154-9. PubMed ID: 6110781
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and pharmacological properties of new derivatives of 1-diphenylacetamide-2-butanol.
Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Zejc A; Gajewczyk L
Pol J Pharmacol Pharm; 1989; 41(5):475-81. PubMed ID: 2577062
[TBL] [Abstract][Full Text] [Related]
37. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.
Horváth K; Andrási F; Botka P; Hámori T
Acta Physiol Hung; 1992; 79(2):153-61. PubMed ID: 1363928
[TBL] [Abstract][Full Text] [Related]
38. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
Wesołowska A
Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
[TBL] [Abstract][Full Text] [Related]
39. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.
Florvall L; Ogren SO
J Med Chem; 1982 Nov; 25(11):1280-6. PubMed ID: 6128419
[TBL] [Abstract][Full Text] [Related]
40. A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity.
Horváth K; Andrási F; Berzsenyi P; Pátfalusi M; Patthy M; Szabó G; Sebestyén L; Bagdy E; Körösi J; Botka P
Arzneimittelforschung; 1989 Aug; 39(8):894-9. PubMed ID: 2573361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
